Moretz, C., Hahn, B., White, J., Goolsby Hunter, A., Essoi, B., Elliott, C., & Ray, R. (2020). Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy. Int J Chron Obstruct Pulmon Dis.

Moretz, Chad, Beth Hahn, John White, Alyssa Goolsby Hunter, Breanna Essoi, Caitlin Elliott, a Riju Ray. "Symptom Burden and GOLD Classification in Medicare Advantage Patients With COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy." Int J Chron Obstruct Pulmon Dis 2020.

Moretz, Chad, et al. "Symptom Burden and GOLD Classification in Medicare Advantage Patients With COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy." Int J Chron Obstruct Pulmon Dis 2020.